Johnson & Johnson (JNJ)

Last Price: 162.38 (2021-01-20)

Company Description

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $82.06B
Net Income (Most Recent Fiscal Year) $15.12B
PE Ratio (Current Year Earnings Estimate) 18.04
PE Ratio (Trailing 12 Months) 19.91
PEG Ratio (Long Term Growth Estimate) 3.11
Price to Sales Ratio (Trailing 12 Months) 5.22
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 6.55
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 13.91
Pre-Tax Margin (Trailing 12 Months) 23.58%
Net Margin (Trailing 12 Months) 21.01%
Return on Equity (Trailing 12 Months) 34.64%
Return on Assets (Trailing 12 Months) 13.40%
Current Ratio (Most Recent Fiscal Quarter) 1.48
Quick Ratio (Most Recent Fiscal Quarter) 1.24
Debt to Common Equity (Most Recent Fiscal Quarter) 0.51
Inventory Turnover (Trailing 12 Months) 3.01
Book Value per Share (Most Recent Fiscal Quarter) $22.60
Earnings per Share (Most Recent Fiscal Quarter) $2.20
Earnings per Share (Most Recent Fiscal Year) $8.68
Diluted Earnings per Share (Trailing 12 Months) $6.36
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers - General
Common Shares Outstanding 2.63B
Free Float 2.63B
Market Capitalization $422.00B
Average Volume (Last 20 Days) 5.74M
Beta (Past 60 Months) 0.70
Percentage Held By Insiders (Latest Annual Proxy Report) 0.27%
Percentage Held By Institutions (Latest 13F Reports) 67.25%
Annual Dividend (Based on Last Quarter) $4.04
Dividend Yield (Based on Last Quarter) 2.52%